Potentiality of Andrographis paniculata in the Management of Diseases and Metabolic Disorders
Defence Life Science Journal · 15.06.2026 · 11 (3) · 279-290
DOI: 10.14429/dlsj.21364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Defence Life Science Journal, online erschienen am 15.06.2026. Verfasst von Kousik Mukherjee und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 2.5).
Abstract (Originalsprache)
Traditional medicinal systems have used several plants and their derivatives to treat diseases. This review aims to summarize the available evidence derived from clinical trials of Andrographis. A total of forty clinical trials, involving 5,252 patients, were reviewed for this study, of which 2,621 patients received Andrographis extracts. Out of the total 40 trials, 35 were randomised controlled trials which indicates that Andrographis is clinically beneficial in infectious diseases such as respiratory infections, COVID-19, HIV, hand foot and mouth disease and malaria. Andrographis is also used for metabolic disorders like diabetes and pre-diabetes; neurological disorders like multiple sclerosis and migraine; gastrointestinal diseases like ulcerative colitis and fatty liver diseases. The current review broadens the evidence based clinical applications of A. paniculata which updates the researchers in exploring its clinical benefits.
Zitieren
APA
Mukherjee, K., Sahu, A. K., Mukherjee, A. K., & Parida, S. (2026). Potentiality of Andrographis paniculata in the Management of Diseases and Metabolic Disorders. Defence Life Science Journal, 11(3), 279-290. https://doi.org/10.14429/dlsj.21364
Vancouver
Mukherjee K, Sahu AK, Mukherjee AK, Parida S. Potentiality of Andrographis paniculata in the Management of Diseases and Metabolic Disorders. Defence Life Science Journal. 2026;11(3):279-290. doi:10.14429/dlsj.21364
BibTeX
@article{Mukherjee2026,
author = {Mukherjee, Kousik and Sahu, Ankit Kumar and Mukherjee, Arup Kumar and Parida, Sagarika},
title = {Potentiality of Andrographis paniculata in the Management of Diseases and Metabolic Disorders},
journal = {Defence Life Science Journal},
year = {2026},
volume = {11},
number = {3},
pages = {279--290},
doi = {10.14429/dlsj.21364}
}
EUVIMED